Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer

As the leading cause of cancer-related deaths, lung cancer remains a noteworthy threat to human health. Although immunotherapies, such as immune checkpoint inhibitors (ICIs), have significantly increased the efficacy of lung cancer treatment, a significant percentage of patients are not sensitive to...

Full description

Saved in:
Bibliographic Details
Main Authors: Junxu Wen, Wenxing Cui, Xiaoyan Yin, Yu Chen, Ailing Liu, Qian Wang, Xiangjiao Meng
Format: Article
Language:English
Published: China Anti-Cancer Association 2025-04-01
Series:Cancer Biology & Medicine
Subjects:
Online Access:https://www.cancerbiomed.org/content/22/4/348
Tags: Add Tag
No Tags, Be the first to tag this record!